DOI QR코드

DOI QR Code

Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum

  • Kim, Young Geun (Department of Plastic and Reconstructive Surgery, Haeundae Paik Hospital, Inje University College of Medicine) ;
  • Oh, Jae Wook (Department of Plastic and Reconstructive Surgery, Haeundae Paik Hospital, Inje University College of Medicine) ;
  • Lee, Keun Cheol (Department of Plastic and Reconstructive Surgery, Haeundae Paik Hospital, Inje University College of Medicine) ;
  • Yoon, Sung Ho (Department of Plastic and Reconstructive Surgery, Haeundae Paik Hospital, Inje University College of Medicine)
  • 투고 : 2022.04.08
  • 심사 : 2022.04.19
  • 발행 : 2022.04.20

초록

Background: Xanthelasma palpebrarum (XP) is a benign periorbital lesion. The relationship between xanthelasma lesion size and serum cholesterol levels has been poorly studied. In this study, we investigated this relationship in the context of the clinical etiology of XP. Methods: We retrospectively reviewed medical records and pathology reports of all patients treated for XP at our hospital between June 2014 and June 2021; the data were used to analyze lesion size, underlying disease, serum cholesterol, and disease recurrence. Results: The mean values for patient age, serum cholesterol, and lesion size were 53.0 years, 235.0 mg/dL, and 69.2 mm2, respectively. XP mainly occurred in women (64.7%); furthermore, the incidence of XP and lesion size was greatest among patients in their 5th decade of life (41.2%). There was no statistically significant relationship between xanthelasma lesion size and serum cholesterol level. Conclusion: This study compared lesion size with various clinical features in XP patients. In patients who underwent surgery for XP, serum cholesterol levels tended to be higher than those in the general population. However, the trend between the size of XP and serum cholesterol level was unclear. Therefore, if a patient with XP visits the hospital for surgery, it is recommended to check the lipid profile to confirm underlying dyslipidemia regardless of the size.

키워드

참고문헌

  1. Wilson E. Xanthelasma or xanthoma. Br Med J 1877;1:184. https://doi.org/10.1136/bmj.1.841.184-b
  2. Rohrich RJ, Janis JE, Pownell PH. Xanthelasma palpebrarum: a review and current management principles. Plast Reconstr Surg 2002;110:1310-4. https://doi.org/10.1097/00006534-200210000-00016
  3. Bergman R. The pathogenesis and clinical significance of xanthelasma palpebrarum. Acad Dermatol 1994;30(2 Pt 1):236-42. https://doi.org/10.1016/S0190-9622(94)70023-0
  4. Pe'er L, Nemet AY. Xanthelasma palpebrarum: an oculoplastic viewpoint of optimal treatment. Adv Ophthalmol Optom 2021;6:341-56. https://doi.org/10.1016/j.yaoo.2021.04.022
  5. Chung YH, Kang SY, Choi WS. A case of intramuscular xanthelasma palpebrarum found during blepharoplasty. Arch Craniofac Surg 2018;19:296-9. https://doi.org/10.7181/acfs.2018.02068
  6. Lee HY, Jin US, Minn KW, Park YO. Outcomes of surgical management of xanthelasma palpebrarum. Arch Plast Surg 2013;40:380-6. https://doi.org/10.5999/aps.2013.40.4.380
  7. Cho SMJ, Lee H, Lee HH, Baek J, Heo JE, Joo HJ, et al. Dyslipidemia fact sheets in Korea 2020: an analysis of nationwide population-based data. J Lipid Atheroscler 2021;10:202-9. https://doi.org/10.12997/jla.2021.10.2.202
  8. Wang KY, Hsu KC, Liu WC, Yang KC, Chen LW. Relationship between xanthelasma palpebrarum and hyperlipidemia. Ann Plast Surg 2018;80(2S Suppl 1):S84-6. https://doi.org/10.1097/SAP.0000000000001310
  9. Kim MJ, Oh TS. Treatment for ophthalmic paralysis: functional and aesthetic optimization. Arch Craniofac Surg 2019;20:3-9. https://doi.org/10.7181/acfs.2019.00066
  10. Lee JH, Woo SS, Shin SH, Kim HJ, Kim JH, Kim SH, et al. Upper eyelid reconstruction using a combination of a nasal septal chondromucosal graft and a Fricke flap: a case report. Arch Craniofac Surg 2021;22:204-8. https://doi.org/10.7181/acfs.2021.00262
  11. Chung CM, Tak SW, Lim H, Cho SH, Lee JW. Early cicatricial lagophthalmos release with pentagonal wedge resection of the scar, fat redistribution, and full-thickness skin grafting. Arch Craniofac Surg 2020;21:49-52. https://doi.org/10.7181/acfs.2019.00584